To assess the clinical relevance of MADD expression in thyroid cancer, we analyzed RNA-seq data from 564 thyroid cancer patients (primarily papillary thyroid cancer patients) from The Cancer Genome Atlas (TCGA) dataset51. This evidence concerns the gene MADD and thyroid gland papillary carcinoma.